Insider Trading & Ownership - Lackner Mark

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Lackner Mark
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2025-02-03
Sale
2025-02-05
6:32 pm
Zentalis Pharmaceuticals Inc. ZNTL Lackner Mark
Chief Scientific Officer
14,368 $1.7115 $24,591 637,570
(Direct)
View
2025-01-02
Sale
2025-01-03
5:17 pm
Zentalis Pharmaceuticals Inc. ZNTL Lackner Mark
Chief Scientific Officer
4,411 $3.12 $13,762 191,317
(Direct)
View
2024-02-02
Sale
2024-02-05
7:15 pm
Zentalis Pharmaceuticals Inc. ZNTL Lackner Mark
Chief Scientific Officer
1,585 $11.54 $18,291 336,728
(Direct)
View
2021-02-08
Sale
2021-02-10
6:53 pm
IDEAYA Biosciences Inc. IDYA Lackner Mark
SVP, Head of Biology
2,000 $21.03 $42,052 101,338
(Direct)
View
2021-01-26
Sale
2021-01-28
4:59 pm
IDEAYA Biosciences Inc. IDYA Lackner Mark
SVP, Head of Biology
2,501 $18.46 $46,158 96,774
(Direct)
View
2020-06-16
Sale
2020-06-18
6:03 pm
IDEAYA Biosciences Inc. IDYA Lackner Mark
SVP, Head of Biology
7,123 $15.19 $108,188 160,784
(Direct)
View
2020-06-02
Sale
2020-06-04
5:40 pm
IDEAYA Biosciences Inc. IDYA Lackner Mark
SVP, Head of Biology
845 $9.2061 $7,779 0
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2025-02-03
Option Award
2025-02-05
6:32 pm
N/A
2035-02-02
Zentalis Pharmaceuticals Inc. ZNTL Lackner Mark
Chief Scientific Officer
460,621 $0 637,570
(Direct)
View
2024-02-01
Option Award
2024-02-05
7:15 pm
N/A
2034-01-31
Zentalis Pharmaceuticals Inc. ZNTL Lackner Mark
Chief Scientific Officer
141,000 $0 336,728
(Direct)
View
2024-01-02
Option Award
2024-01-03
8:21 pm
N/A
2034-01-02
Zentalis Pharmaceuticals Inc. ZNTL Lackner Mark
Chief Scientific Officer
100,000 $0 116,313
(Direct)
View

Ownership
2024-01-03
8:19 pm
N/A
N/A
Zentalis Pharmaceuticals Inc. ZNTL Lackner Mark
Chief Scientific Officer
0 $0 255,000
(Direct)
View
2021-02-24
Option Award
2021-02-26
7:10 pm
N/A
2031-02-23
IDEAYA Biosciences Inc. IDYA Lackner Mark
SVP, Head of Biology
45,000 $0 45,000
(Direct)
View
2021-02-08
Exercise
2021-02-10
6:53 pm
N/A
2028-12-11
IDEAYA Biosciences Inc. IDYA Lackner Mark
SVP, Head of Biology
2,000 $0 101,338
(Direct)
View
2021-02-08
Exercise
2021-02-10
6:53 pm
N/A
N/A
IDEAYA Biosciences Inc. IDYA Lackner Mark
SVP, Head of Biology
2,000 $6.98 101,338
(Direct)
View
2021-01-26
Exercise
2021-01-28
4:59 pm
N/A
N/A
IDEAYA Biosciences Inc. IDYA Lackner Mark
SVP, Head of Biology
377 $4.62 96,774
(Direct)
View
2021-01-26
Exercise
2021-01-28
4:59 pm
N/A
2028-06-20
IDEAYA Biosciences Inc. IDYA Lackner Mark
SVP, Head of Biology
1,500 $0 96,774
(Direct)
View
2021-01-26
Exercise
2021-01-28
4:59 pm
N/A
N/A
IDEAYA Biosciences Inc. IDYA Lackner Mark
SVP, Head of Biology
1,123 $6.98 96,774
(Direct)
View
2020-06-16
Exercise
2020-06-18
6:03 pm
N/A
N/A
IDEAYA Biosciences Inc. IDYA Lackner Mark
SVP, Head of Biology
4,260 $4.62 160,784
(Direct)
View
2020-06-16
Exercise
2020-06-18
6:03 pm
N/A
2028-06-20
IDEAYA Biosciences Inc. IDYA Lackner Mark
SVP, Head of Biology
7,123 $0 160,784
(Direct)
View
2020-06-16
Exercise
2020-06-18
6:03 pm
N/A
N/A
IDEAYA Biosciences Inc. IDYA Lackner Mark
SVP, Head of Biology
2,863 $6.98 160,784
(Direct)
View